Device Trial Radar · NCT04295707
Monthly Replacement Orthokeratology for Myopia Control in Existing Lens Wearers
Last checked: Nov 20, 2026Latest source record: Jul 19, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
80
Planned (sponsor's estimate)
Start
Mar 11, 2020
Primary completion
Jun 2023
Study completion Aug 2023
Sponsor
- Lead sponsor
- The Hong Kong Polytechnic UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Menicon Co., Ltd.
- First posted
- Mar 4, 2020
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 8 years, up to 15 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The two-year prospective study aims at investigating the benefits of frequent replacement (monthly) orthokeratology lenses in myopia control in terms of effectiveness in control and prevention of ocular complications. The secondary objective will be investigating the use of weekly protein removal system in monthly replacement modality orthokeratology lenses on surface deposit.
Conditions
- Myopic Progression
Interventions
orthokeratologyDevice
Nightly wear of orthokeratology lenses to correct vision in the daytime
Menicon Progent A+BDevice
Menicon Progent A+B is a commercially available protein remover for rigid lenses. It has received FDA clearance and been launched in Hong Kong for over a decade. The product contains two separate sterile solutions, one with sodium hypochlorite and the other with potassium bromide. By mixing the two solutions in a special vial, it can clean and remove protein deposits on the lenses. Parents of subjects assigned to use weekly protein remover will be required to soak the cleansed lenses in the solution mixture for not more than 30 mins every week. All lenses must be rinsed thoroughly with saline and cleansed with daily cleaner again before daily disinfection.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Axial elongation in 2 yearsTime frame: 2 years
- Back Surface Lens DepositsTime frame: Every month up to 12 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
School of Optometry, The Hong Kong Polytechnic University
Kowloon, Hong Kong
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.